Literature DB >> 2904005

Transmission of hepatitis B from hepatitis-B-seronegative subjects.

V Thiers1, E Nakajima, D Kremsdorf, D Mack, H Schellekens, F Driss, A Goudeau, J Wands, J Sninsky, P Tiollais.   

Abstract

The polymerase chain reaction (PCR) was used to identify and characterise serum HBV DNA sequences in 3 patients negative for all HBV serological markers. HBsAg determinants were detected in 1 individual by monoclonal anti-HBsAg immunoradiometric assay. By use of sets of primers on the S and pre-S parts of the HBV genome the presence of HBV DNA was demonstrated in the serum of all 3 patients. Inoculation of human sera to 2 chimpanzees induced acute hepatitis in both animals; 1 became positive for HBsAg and anti-HBcAg and the other only for anti-HBsAg. Cloning of DNA sequences from viral isolates from 1 chimpanzee and 1 patient was accomplished after amplification of the 3' region of the S gene. Comparison of the partial nucleotide sequence with that of known HBV subtypes showed 0 and 1 point mutation, respectively, in the highly conserved 3' end of the S gene. Therefore the results show that PCR with HBV primers may unambigously identify HBV infectious particles among non-A, non-B viruses and is a potentially useful diagnostic test for detection of HBV DNA sequences in serum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904005     DOI: 10.1016/s0140-6736(88)92891-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  41 in total

Review 1.  Occult hepatitis B: clinical implications and treatment decisions.

Authors:  Paul Schmeltzer; Kenneth E Sherman
Journal:  Dig Dis Sci       Date:  2010-10-07       Impact factor: 3.199

2.  Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection.

Authors:  B Vandercam; C Cornu; J L Gala; A Geubel; M Cahill; M E Lamy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

Review 3.  Hepatitis B virus. New and evolving issues.

Authors:  B Yoffe; C A Noonan
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

4.  Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.

Authors:  C Transy; G Fourel; W S Robinson; P Tiollais; P L Marion; M A Buendia
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 5.  Cytotoxic T cells and viral hepatitis.

Authors:  F V Chisari
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Direct method for detecting small quantities of hepatitis B virus DNA in serum and plasma using the polymerase chain reaction.

Authors:  J B Zeldis; J H Lee; D Mamish; D J Finegold; R Sircar; Q Ling; P J Knudsen; I K Kuramoto; L T Mimms
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

7.  Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients.

Authors:  Y M Lo; E S Lo; W Z Mehal; M Sampietro; G Fiorelli; G Ronchi; C H Tse; K A Fleming
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

8.  Limited infection with occult hepatitis B virus in drug users in the USA.

Authors:  Jason T Blackard; Christina M Martin; Satarupa Sengupta; Janet Forrester
Journal:  Hepatol Res       Date:  2012-08-22       Impact factor: 4.288

9.  Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

Authors:  C M Martin; J A Welge; N J Shire; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2009-11-02       Impact factor: 3.728

10.  Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria.

Authors:  Emmanuel Nna; Chinenye Mbamalu; Ifeoma Ekejindu
Journal:  Pathog Glob Health       Date:  2014-07-04       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.